Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2025-12-25 @ 10:09 PM
NCT ID: NCT02719158
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were reported during dosing and up to 1 month following dosing.
Study: NCT02719158
Study Brief: Dose Ranging Study of OTO-201 in AOMT
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
6 mg OTO-201 6 mg ciprofloxacin: single administration of OTO-201 0 None 0 38 5 38 View
12 mg OTO-201 12 mg ciprofloxacin: single administration of OTO-201 0 None 0 38 6 38 View
Control Sham Control: simulated, single administration 0 None 0 19 1 19 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Otitis media acute SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (18.1) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.1) View